Nearly 20 diseases studied by our researchers, including:
- Infectious diseases (COVID-19, Ebola, influenza, measles and respiratory syncytial virus)
- Inflammatory diseases (inflammatory bowel disease and chronic obstructive pulmonary disease)
- Sexually transmitted infections
- Cardiovascular diseases and diabetes
Innovative academic degree programs that combine studies in science, business and law
Research centers focused on microbial pathogenesis, translational immunology and inflammation, immunity and infection
National Institutes of Health-funded cooperative research centers nationwide that were created to advance development of vaccines for sexually transmitted infections.
Including J. Mack Robinson College of Business, College of Law, College of Arts & Sciences and Honors College
Our researchers are developing new vaccines, diagnostics and therapeutics to tackle some of the world’s biggest health issues. To bring these biomedical inventions to the market, they’d like to work with pharmaceutical and biotech companies, foundations, industry sponsors and donors who want to improve the health of people worldwide. Learn more about our patents and inventions.
We’re ready to partner with you. Please contact us to collaborate on research projects, fund preliminary pilot studies designed to advance human health or discuss commercialization opportunities.
Director of Communications
Institute for Biomedical Sciences
Parker H. Petit Science Center
100 Piedmont Ave
Atlanta, GA 30303